|
GPBP1L1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.26560000005094E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.82726999999883E-05 |
| Normal-vs-Stage2 |
6.862300E-03 |
| Normal-vs-Stage3 |
7.818400E-04 |
| Normal-vs-Stage4 |
8.781500E-03 |
| Stage1-vs-Stage2 |
9.220000E-01 |
| Stage1-vs-Stage3 |
3.642000E-01 |
| Stage1-vs-Stage4 |
5.158800E-01 |
| Stage2-vs-Stage3 |
5.292000E-01 |
| Stage2-vs-Stage4 |
5.368800E-01 |
| Stage3-vs-Stage4 |
9.598800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.05260000002627E-06 |
| Normal-vs-AfricanAmerican |
3.972500E-04 |
| Normal-vs-Asian |
1.175050E-03 |
| Caucasian-vs-AfricanAmerican |
9.138400E-01 |
| Caucasian-vs-Asian |
4.918000E-01 |
| AfricanAmerican-vs-Asian |
3.969600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.30620000049886E-07 |
| Normal-vs-Female |
2.125500E-02 |
| Male-vs-Female |
1.789560E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.819100E-04 |
| Normal-vs-Extreme_Weight |
4.64909999997598E-06 |
| Normal-vs-Obese |
1.581400E-03 |
| Normal-vs-Extreme_Obese |
7.665700E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.393400E-01 |
| Normal_Weight-vs-Obese |
4.693800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.182600E-01 |
| Extreme_Weight-vs-Obese |
3.461800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.722600E-01 |
| Obese-vs-Extreme_Obese |
8.439200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.119900E-02 |
| Normal-vs-Age(41-60Yrs) |
1.758480E-03 |
| Normal-vs-Age(61-80Yrs) |
8.39110000039334E-07 |
| Normal-vs-Age(81-100Yrs) |
2.598000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.698800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.521600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.642570E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.206640E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.246560E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.586600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.444650E-03 |
| Normal-VS-Type2 PRCC |
8.36400004811111E-09 |
| Normal-VS-KIRP CIMP |
1.133650E-01 |
| Normal-VS-Unclassified PRCC |
2.976400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.227300E-04 |
| Type1 PRCC-VS-KIRP CIMP |
7.603200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.824600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.158200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.962000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.570000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.04780004064986E-09 |
| Normal-vs-N1 |
6.264900E-03 |
| Normal-vs-N2 |
1.371640E-02 |
| N0-vs-N1 |
1.471440E-01 |
| N0-vs-N2 |
7.355400E-01 |
| N1-vs-N2 |
7.540000E-01 |
|
|
